Confo Therapeutics
Drug discovery company building internal drug discovery.
Launch date
Employees
Market cap
-
Enterprise valuation
€240—360m (Dealroom.co estimates Jul 2024.)
Company register number 0632.474.939
Ghent East Flanders (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | - | - | - | 2.5m | <1m | 46.6m |
| % growth | - | - | - | - | (80 %) | 9210 % |
| EBITDA | (3.2m) | (5.3m) | (8.5m) | (9.6m) | (14.9m) | - |
| % EBITDA margin | - | - | - | (386 %) | (2975 %) | - |
| Profit | (3.5m) | (5.7m) | (8.9m) | (9.9m) | (15.6m) | 31.1m |
| % profit margin | - | - | - | (397 %) | (3117 %) | 67 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
€3.0m | Seed | ||
€6.7m | Series A | ||
€1.6m | Grant | ||
* | €1.0m | Grant | |
* | €30.0m | Series A | |
* | €1.7m | Grant | |
* | €1.6m | Grant | |
* | €60.0m | Series B | |
| Total Funding | €106m | ||
Recent News about Confo Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.